PBI Reports 49-Percent Rise in Q2 Revenues, Plans to Focus on Mass-Spec Sample Prep

"The number of customers using our PCT platform in the workflow for mass spectrometry has increased dramatically in the last year, and so we're addressing that market particularly," said PBI's CEO.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.